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CLUSIONS: Five methods of measuring BLISS attainment using
four pre-speciﬁed threshold levels of pain were able to statisti-
cally discriminate between treatment groups. This method may
potentially provide an approach, to deﬁning which patients not
only improve but also achieve a good state of health, at low and
very low levels of pain intensity. BLISS -10 is a therapeutically
attainable very low symptom state at which clinically important,
statistically signiﬁcant between group differences are detectable,
and therefore may provide a benchmark against which thera-
peutic interventions can be assessed. However, the value to
patients, of this and other low and very low intensity pain states,
requires further elaboration.
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OBJECTIVE: To evaluate osteoarthritis (OA) patients’ ability to
state valid preferences for tradeoffs between treatment-related
serious adverse events (SAEs) and speciﬁed treatment beneﬁts.
METHODS: A web-enabled, choice-format, conjoint or stated-
preference survey was developed to elicit OA patients’ willing-
ness to accept tradeoffs between SAE probabilities and treatment
efﬁcacy. The treatment attributes included in the tradeoff tasks
employed graphical elements indicating pain and stiffness sever-
ity on a continuous visual analog scale, mild-to-moderate gas-
trointestinal (GI) symptoms measured by type of intervention
required, and bleeding ulcer, heart infarct, and stroke probabil-
ities shown numerically and visually on a 100-square grid. The
instrument was pretested with a convenience sample of 8 OA
patients and administered to a sample of OA patients in a large-
scale pilot survey. Random-parameter logit estimates were used
to calculate maximum acceptable 10-year MAR various levels of
clinical beneﬁt. RESULTS: A total of 156 patients completed the
pilot survey. Only 4% of subjects failed the irrational-choice and
14% failed the cross-question monotonicity internal validity
tests. Patients discriminated successfully among pain and SAE
risk levels. Mild-to-moderate gastrointestinal side effects had no
signiﬁcant effect on treatment choices. Pain control was about
twice as important as control of stiffness, and stroke likelihood
was the most important SAE risk. Maximum acceptable risk
(MAR) increased as expected with greater therapeutic beneﬁts
and decreased inversely with the importance of SAE risks. Mean
MAR for a maximal improvement from moderate daily symp-
toms to full symptom control was signiﬁcantly greater than 0.05
for ulcer, infarct, and stroke (p < 0.001 for all). CONCLU-
SIONS: All medical interventions carry risks of adverse outcomes
that must be evaluated against their clinical beneﬁts. OA patients
in this pilot study indicated they were willing to accept SAE risks
in excess of clinical levels for sufﬁciently large improvements in
symptom control.
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OBJECTIVES: To characterize health related quality of life
(HRQoL) among persons with and without arthritis or chronic
joint symptoms (CJS). METHODS: Data obtained from the
2004 Behavioral Risk Factor Surveillance Survey (BRFSS), an
ongoing, state-based, random-digit-dialed telephone survey of
non-institutionalized persons aged >/= 18 years conducted in all
states. Data from nine states (54,116 participants) were included
in the analysis as these states had included both components of
arthritis and HRQoL measures (mental, physical, and poor
health) in the 2004 survey. Multiple linear regression analyses
were used to examine the associations between selected sociode-
mographic and behavioral determinants and HRQoL among
participants with arthritis or CJS. RESULTS: Of the respondents
32% had been diagnosed with some form of arthritis by a health
care professional and 46% had joint pain in the past 30 days.
The respondents with arthritis had a mean of 6.75 physically and
4.58 mentally unhealthy days and 6.41 poor health days during
the past 30 days compared with 2.29, 3.14, and 2.76 among
those without arthritis. Only 36.9% of participants with arthri-
tis reported very good general health versus 60.9% of respon-
dents without arthritis (p = 0.000). For each unit of age increase
of participants with arthritis there was an increase in physical,
mental, and poor unhealthy days. Based on WHO’s classiﬁcation
of obesity, the respondents with arthritis included approximately
30.9% normal weight, 37.3% overweight, 27% obese, and
4.7% severely obese respondents. Regression analysis indicated
that severely obese, obese, and over weight experienced more
unhealthy physical and poor days than respondents with normal
weight. Active men and women were less likely to report poor
unhealthy days compared with those who did not exercise in the
past 30 days. CONCLUSIONS: Findings indicate that persons
with arthritis or CJS experience a decrease in HRQOL as com-
pared to those without arthritis.
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OBJECTIVES: Osteoarthritis is prevalent and debilitating
disease that affects nearly 21 million Americans. For clinicians
to assess the impact of treatment strategies require reliable, valid
and interpretable measures. We conducted a systematic review
of WOMAC which is a disease speciﬁc instrument measuring
HRQL of patients with osteoarthritis. The review considered the
evaluative, discriminative properties and interpretability of the
instrument. The last systematic review was published in 2001.
METHODS: A structured literature review was performed to
identify evidence related to measurement properties (reliability,
internal consistency, responsiveness, and interpretability) of
WOMAC using two databases (MEDLINE and HealthSTAR)
from 1982 to December 2005. We included randomized con-
trolled trials and observational studies. RESULTS: Of 307 and
137 papers, 14 met the inclusion criterion. Discriminative: We
found high reliability (correlation coefﬁcients) for domains of
pain and physical function (>0.7), compared to the stiffness
domain (>0.6). All domains had generally high construct valid-
ity in differentiating among patients with better/worse HRQL.
The internal consistency (Cronbach’s alpha) was high (>0.8).
WOMAC generally had high construct validity. Responsiveness
varied by domain and by intervention. WOMAC was more
responsive in patients who underwent total hip or knee arthro-
plasty compared to other interventions. We found that the phys-
ical function domain was more responsive than other domains
